ArticleMolecular medicine reports2024

Doxorubicin‑induced cardiomyopathy is mitigated by empagliflozin via the modulation of endoplasmic reticulum stress pathways.

Akshi Malik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.